Stock Events

Stock Events

Search...

Nektar Therapeutics (NKTR) Q4 2024 Earnings

7NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.25

-0.23

-0.2

-0.18

Details

Expected EPS

-0.199013

Actual EPS

-0.18

Surprise EPS

0.02

Surprise Percent

+9.55%

Description

Nektar Therapeutics (NKTR) has reported earnings of -0.18 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.